REQUEST A DEMO
Total
USD $0.00
Search more companies

Alpha Pharmaceutical Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Alpha Pharmaceutical Sp. z o.o. Profile Updated: August 19, 2020
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Alpha Pharmaceutical Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on February 11, 2020. From the latest financial highlights, Alpha Pharmaceutical Sp. z o.o. reported a net sales revenue increase of 206.29% in 2023. During that time, Alpha Pharmaceutical Sp. z o.o.’s total assets grew by 61.79%. The net profit margin of Alpha Pharmaceutical Sp. z o.o. increased by 0.99% in 2023.

Headquarters
Ul. Pirenejska 9 28
Warsaw; Mazowieckie; Postal Code: 01-493

Contact Details: Purchase the Alpha Pharmaceutical Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Alpha Pharmaceutical Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Alpha Pharmaceutical Sp. z o.o. report to view the information.
Incorporation Date:
February 11, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Alpha Pharmaceutical Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
206.29%
Total operating revenue
201.12%
Operating profit (EBIT)
388.31%
Net Profit (Loss) for the Period
258.96%
Total assets
61.79%
Total equity
34.59%
Operating Profit Margin (ROS)
3.52%
Net Profit Margin
0.99%
Return on Equity (ROE)
16.06%
Quick Ratio
-5.74%
Cash Ratio
-5.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?